Lu AE58054

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lu AE58054
Lu-AE58054.svg
Systematic (IUPAC) name
2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine
Clinical data
Legal status ?
Identifiers
CAS number 467459-31-0 N
ATC code None
ChemSpider 19878969 N
Synonyms Lu-AE-58054
Chemical data
Formula C20H19F5N2O 
Mol. mass 398.37 g/mol
 N (what is this?)  (verify)

Lu AE58054 is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia.[1][2] As of October 2013 it is in phase III clinical trials.[2]

References[edit]

External links[edit]